[go: up one dir, main page]

DK136492D0 - A pharmaceutical formulation - Google Patents

A pharmaceutical formulation

Info

Publication number
DK136492D0
DK136492D0 DK136492A DK136492A DK136492D0 DK 136492 D0 DK136492 D0 DK 136492D0 DK 136492 A DK136492 A DK 136492A DK 136492 A DK136492 A DK 136492A DK 136492 D0 DK136492 D0 DK 136492D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
DK136492A
Other languages
English (en)
Inventor
Hans Holmegaard Soerensen
Lars Skriver
Annie Rassing Hoelgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK136492A priority Critical patent/DK136492D0/da
Publication of DK136492D0 publication Critical patent/DK136492D0/da
Priority to DE69233704T priority patent/DE69233704T2/de
Priority to DE10399015C priority patent/DE10399015I1/de
Priority to EP01128974A priority patent/EP1197222B1/en
Priority to ES01128974T priority patent/ES2291264T3/es
Priority to PT93902089T priority patent/PT618807E/pt
Priority to PCT/DK1992/000379 priority patent/WO1993012812A1/en
Priority to RU94045932A priority patent/RU2122426C1/ru
Priority to CA002125855A priority patent/CA2125855C/en
Priority to RO94-01056A priority patent/RO111990B1/ro
Priority to AU33446/93A priority patent/AU667503B2/en
Priority to EP93902089A priority patent/EP0618807B1/en
Priority to HU9401832A priority patent/HUT69402A/hu
Priority to DK93902089T priority patent/DK0618807T3/da
Priority to NZ246556A priority patent/NZ246556A/en
Priority to JP5511361A priority patent/JP2950617B2/ja
Priority to CZ941507A priority patent/CZ283361B6/cs
Priority to AT01128974T priority patent/ATE368472T1/de
Priority to SK754-94A priority patent/SK279641B6/sk
Priority to KR1019940702139A priority patent/KR100266502B1/ko
Priority to UA94005308A priority patent/UA41502C2/uk
Priority to AT93902089T priority patent/ATE227583T1/de
Priority to ES93902089T priority patent/ES2185625T3/es
Priority to DE69232847T priority patent/DE69232847T2/de
Priority to MX9207374A priority patent/MX9207374A/es
Priority to IL104152A priority patent/IL104152A/en
Priority to CN93121067A priority patent/CN1056537C/zh
Priority to BG98806A priority patent/BG63075B1/bg
Priority to FI942906A priority patent/FI115116B/fi
Priority to NO942300A priority patent/NO942300L/no
Priority to US08/458,386 priority patent/US5849704A/en
Priority to US08/458,385 priority patent/US5849700A/en
Priority to US09/121,386 priority patent/US6022858A/en
Priority to JP11026405A priority patent/JPH11315031A/ja
Priority to NL300126C priority patent/NL300126I1/nl

Links

DK136492A 1991-12-20 1992-11-10 A pharmaceutical formulation DK136492D0 (da)

Priority Applications (35)

Application Number Priority Date Filing Date Title
DK136492A DK136492D0 (da) 1992-11-10 1992-11-10 A pharmaceutical formulation
DE69232847T DE69232847T2 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
CZ941507A CZ283361B6 (cs) 1991-12-20 1992-12-16 Farmaceutický přípravek obsahující růstový hormon a histidin
AT01128974T ATE368472T1 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
EP01128974A EP1197222B1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
ES01128974T ES2291264T3 (es) 1991-12-20 1992-12-16 Formulacion farmaceutica estabilizada comprendiendo una hormona de crecimiento e histidina.
PT93902089T PT618807E (pt) 1991-12-20 1992-12-16 Formulacao farmaceutica estabilizada compreendendo a hormona de crescimento humano e a histidina
PCT/DK1992/000379 WO1993012812A1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
RU94045932A RU2122426C1 (ru) 1991-12-20 1992-12-16 Фармацевтический препарат, содержащий гормон роста или производное гормона роста и гистидин или производное гистидина, препарат, представляющий собой кристаллы гормона роста, содержащие гистидин или производное гистидина и способ получения кристаллов гормона роста и гистидина или производного гистидина
CA002125855A CA2125855C (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
RO94-01056A RO111990B1 (ro) 1991-12-20 1992-12-16 Preparate farmaceutice, continand un hormon de crestere sau un derivat al acestuia, si procedeu de preparare
AU33446/93A AU667503B2 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
KR1019940702139A KR100266502B1 (ko) 1991-12-20 1992-12-16 성장호르몬과히스티딘으로이루어지는안정화된약학제제
HU9401832A HUT69402A (en) 1991-12-20 1992-12-16 Process for producing stabilized pharmaceutical formulations comprising growth hormone and histidine
DK93902089T DK0618807T3 (da) 1991-12-20 1992-12-16 Stabiliseret farmaceutisk formulering omfattende human væksthormon og histidin
NZ246556A NZ246556A (en) 1991-12-20 1992-12-16 Pharmaceutical composition of a growth hormone and histidine
JP5511361A JP2950617B2 (ja) 1991-12-20 1992-12-16 成長ホルモンおよびヒスチジンを含んでなる安定化医薬製剤
DE69233704T DE69233704T2 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische Formulierung, umfassend Wachstumshormon und Histidin
SK754-94A SK279641B6 (sk) 1991-12-20 1992-12-16 Stabilizovaný farmaceutický prípravok obsahujúci r
DE10399015C DE10399015I1 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
EP93902089A EP0618807B1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
UA94005308A UA41502C2 (uk) 1991-12-20 1992-12-16 Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
AT93902089T ATE227583T1 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
ES93902089T ES2185625T3 (es) 1991-12-20 1992-12-16 Formulacion farmaceutica estabilizada que incluye hormona de crecimiento e histidina.
MX9207374A MX9207374A (es) 1991-12-20 1992-12-17 Preparacion farmaceutica que comprende una hormonade crecimiento o un derivado de la hormona de crecimiento e histidina o un derivado de histidina.
IL104152A IL104152A (en) 1991-12-20 1992-12-18 A stabilized pharmaceutical preparation containing the growth hormone and histidine
CN93121067A CN1056537C (zh) 1992-11-10 1993-11-10 一种药物制剂
BG98806A BG63075B1 (bg) 1991-12-20 1994-05-30 Използване на хистидин за инхибиране на деамидирането на растежен хормон
FI942906A FI115116B (fi) 1991-12-20 1994-06-17 Menetelmä kasvuhormonia ja histidiiniä sisältävien kiteiden valmistamiseksi
NO942300A NO942300L (no) 1991-12-20 1994-06-17 Stabilisert farmasöytisk preparat som omfatter veksthormon og histidin
US08/458,386 US5849704A (en) 1991-12-20 1995-06-02 Pharmaceutical formulation
US08/458,385 US5849700A (en) 1991-12-20 1995-06-02 Pharmaceutical formulation
US09/121,386 US6022858A (en) 1991-12-20 1998-07-23 Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
JP11026405A JPH11315031A (ja) 1991-12-20 1999-02-03 成長ホルモンおよびヒスチジンを含んでなる安定化医薬製剤
NL300126C NL300126I1 (nl) 1991-12-20 2003-05-01 Gestabiliseerde farmaceutische formulering die groeihormoon en histidine omvat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK136492A DK136492D0 (da) 1992-11-10 1992-11-10 A pharmaceutical formulation

Publications (1)

Publication Number Publication Date
DK136492D0 true DK136492D0 (da) 1992-11-10

Family

ID=8104046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK136492A DK136492D0 (da) 1991-12-20 1992-11-10 A pharmaceutical formulation

Country Status (2)

Country Link
CN (1) CN1056537C (da)
DK (1) DK136492D0 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS64438B1 (sr) * 2018-10-26 2023-09-29 Novo Nordisk As Stabilne kompozicije semaglutida i njihova upotreba
CN111329996B (zh) * 2020-03-03 2023-11-03 上海联合赛尔生物工程有限公司 重组人生长激素的组合物和其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0374120A3 (en) * 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides

Also Published As

Publication number Publication date
CN1056537C (zh) 2000-09-20
CN1096222A (zh) 1994-12-14

Similar Documents

Publication Publication Date Title
FI934914A (fi) Farmaceutiska formuleringar
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
FI922316A (fi) Farmaceutisk sammansaettning
NO942923L (no) Medikamenter
FI930882A (fi) Farmaceutiska foereningar
FI923581A (fi) Farmaceutisk kombinationsformation
NO923859D0 (no) Medikament
NO931831D0 (no) Farmasoeytiske blandinger
BR9207062A (pt) Formulação em comprimido
NO934145D0 (no) Farmas!ytiske forbindelser
DE4294862T1 (de) Pharmazeutische Komposition
FI931251A (fi) Farmaceutiska foereningar
DK0587047T3 (da) Farmaceutisk præparat på gestagenbasis
DK86492D0 (da) Laegemiddel
NO961589D0 (no) Farmasöytiske blandinger
DK0511991T3 (da) Farmaceutisk formulering
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DK136492D0 (da) A pharmaceutical formulation
IS3836A (is) Lyfjaskammtari
NO920039L (no) Farmasoeytiske preparater
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater
KR920010907U (ko) 약제 살포기
ITMI922581A1 (it) Composizione farmaceutica